tiprankstipranks
GlaxoSmithKline Pharmaceuticals Limited (IN:GLAXO)
:GLAXO
India Market
GLAXO
GlaxoSmithKline Pharmaceuticals Limited
RESEARCH TOOLSreports

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Ratios

7 Followers

GlaxoSmithKline Pharmaceuticals Limited Ratios

IN:GLAXO's free cash flow for Q2 2026 was ₹0.48. For the 2026 fiscal year, IN:GLAXO's free cash flow was decreased by ₹ and operating cash flow was ₹0.36. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.78 1.79 1.84 1.88 2.18
Quick Ratio
 1.46 1.54 1.49 1.53 1.87
Cash Ratio
 0.45 0.28 0.04 0.03 0.17
Solvency Ratio
 0.56 0.46 0.35 0.41 0.88
Operating Cash Flow Ratio
 0.11 0.68 0.38 0.37 0.48
Short-Term Operating Cash Flow Coverage
 13.36 0.00 47.72 11.53 13.19
Net Current Asset Value
₹ 10.14B₹ 12.53B₹ 10.19B₹ 9.09B₹ 17.38B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.02 <0.01 0.01 <0.01 <0.01
Debt-to-Capital Ratio
 0.02 <0.01 0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 2.15 2.11 2.00 1.91 1.74
Debt Service Coverage Ratio
 66.36 844.19 46.75 12.78 5.43
Interest Coverage Ratio
 454.54 944.92 756.21 684.80 580.26
Debt to Market Cap
 <0.01 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
 2.27 0.66 1.21 1.02 1.23
Net Debt to EBITDA
 -0.49 -0.40 -0.05 -0.02 -0.36
Profitability Margins
Gross Profit Margin
57.73%60.47%60.76%59.89%57.96%
EBIT Margin
36.91%33.85%24.29%23.02%21.32%
EBITDA Margin
38.71%35.64%25.50%24.25%22.66%
Operating Profit Margin
32.49%29.91%39.38%38.12%35.33%
Pretax Profit Margin
36.84%33.81%23.63%25.72%23.77%
Net Profit Margin
27.03%24.89%17.08%18.78%51.70%
Continuous Operations Profit Margin
27.03%24.89%17.08%18.69%11.62%
Net Income Per EBT
73.37%73.62%72.28%73.01%217.54%
EBT Per EBIT
113.38%113.06%60.00%67.48%67.26%
Return on Assets (ROA)
27.86%22.58%16.59%18.36%36.58%
Return on Equity (ROE)
56.08%47.54%33.19%35.07%63.64%
Return on Capital Employed (ROCE)
61.62%50.59%66.95%61.97%39.47%
Return on Invested Capital (ROIC)
44.91%37.12%47.82%43.83%18.82%
Return on Tangible Assets
27.92%22.65%16.70%18.55%36.85%
Earnings Yield
2.56%1.96%1.75%2.71%5.68%
Efficiency Ratios
Receivables Turnover
 11.34 10.33 9.87 9.85 15.97
Payables Turnover
 3.33 2.08 2.17 2.09 2.38
Inventory Turnover
 2.98 3.06 2.58 2.84 2.58
Fixed Asset Turnover
 12.65 13.13 11.11 10.32 10.07
Asset Turnover
 1.03 0.91 0.97 0.98 0.71
Working Capital Turnover Ratio
 5.82 2.68 2.83 2.05 2.29
Cash Conversion Cycle
 45.06 -20.78 9.95 -9.26 11.03
Days of Sales Outstanding
 32.18 35.35 36.98 37.04 22.85
Days of Inventory Outstanding
 122.52 119.37 141.41 128.74 141.61
Days of Payables Outstanding
 109.63 175.50 168.44 175.04 153.43
Operating Cycle
 154.69 154.72 178.39 165.78 164.46
Cash Flow Ratios
Operating Cash Flow Per Share
 10.85 76.14 34.36 28.44 45.30
Free Cash Flow Per Share
 9.84 74.78 32.51 25.85 43.36
CapEx Per Share
 1.01 1.36 1.84 2.59 1.94
Free Cash Flow to Operating Cash Flow
 0.91 0.98 0.95 0.91 0.96
Dividend Paid and CapEx Coverage Ratio
 0.25 1.67 1.02 0.31 1.50
Capital Expenditure Coverage Ratio
 10.78 56.03 18.64 11.00 23.40
Operating Cash Flow Coverage Ratio
 5.15 129.64 31.18 31.16 40.38
Operating Cash Flow to Sales Ratio
 0.05 0.35 0.17 0.15 0.25
Free Cash Flow Yield
0.42%2.67%1.64%1.95%2.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 38.72 51.09 57.04 36.93 17.60
Price-to-Sales (P/S) Ratio
 10.46 12.72 9.74 6.94 9.10
Price-to-Book (P/B) Ratio
 23.15 24.29 18.93 12.95 11.20
Price-to-Free Cash Flow (P/FCF) Ratio
 237.13 37.41 61.09 51.24 38.44
Price-to-Operating Cash Flow Ratio
 215.14 36.74 57.81 46.58 36.80
Price-to-Earnings Growth (PEG) Ratio
 5.63 0.89 -19.67 0.54 0.69
Price-to-Fair Value
 23.15 24.29 18.93 12.95 11.20
Enterprise Value Multiple
 26.55 35.29 38.16 28.58 39.81
Enterprise Value
 391.71B 468.60B 336.04B 225.35B 295.69B
EV to EBITDA
 26.79 35.29 38.16 28.58 39.81
EV to Sales
 10.37 12.58 9.73 6.93 9.02
EV to Free Cash Flow
 234.98 36.99 61.01 51.19 38.10
EV to Operating Cash Flow
 213.19 36.33 57.74 46.54 36.47
Tangible Book Value Per Share
 100.32 114.40 103.54 100.27 146.85
Shareholders’ Equity Per Share
 100.80 115.19 104.93 102.27 148.78
Tax and Other Ratios
Effective Tax Rate
 0.27 0.26 0.28 0.27 0.51
Revenue Per Share
 222.98 219.95 203.87 190.99 183.15
Net Income Per Share
 60.27 54.76 34.83 35.87 94.69
Tax Burden
 0.73 0.74 0.72 0.73 2.18
Interest Burden
 1.00 1.00 0.97 1.12 1.11
Research & Development to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
SG&A to Revenue
 0.15 0.19 0.18 0.18 0.19
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
Income Quality
 0.16 1.39 0.99 0.58 0.33
Currency in INR